Cargando…

Exploring Novel Endpoints for Clinical Trials in Kidney Disease: Challenges and Opportunities

Detalles Bibliográficos
Autor principal:	Roy-Chaudhury, Prabir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720537/ https://www.ncbi.nlm.nih.gov/pubmed/29318213 http://dx.doi.org/10.1016/j.ekir.2017.04.001

Ejemplares similares

Digital endpoints in clinical trials of Alzheimer’s disease and other neurodegenerative diseases: challenges and opportunities
por: Brem, Anna-Katharine, et al.
Publicado: (2023)

Solid cancer: the new tumour spread endpoint opens novel opportunities
por: Fernandes, Michael, et al.
Publicado: (2019)

The Importance of Endpoints in Oncology Clinical Trials
por: Faiman, Beth
Publicado: (2023)

Exploring Dual Pathology: Opportunities and Challenges
por: Cuartas-Arias, Mauricio
Publicado: (2023)

Academically led clinical trials: challenges and opportunities
por: Turajlic, S., et al.
Publicado: (2015)

Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges
por: Angel, Juana, et al.
Publicado: (2014)

mHealth technologies in clinical trials: Opportunities and challenges
por: Kakkar, Ashish Kumar, et al.
Publicado: (2018)

Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation
por: Hilbrands, Luuk, et al.
Publicado: (2022)

Challenges and Opportunities for Lung Ultrasound in Novel Coronavirus Disease (COVID-19)
por: Schultz, Marcus J., et al.
Publicado: (2020)

Early Adventitial Activation and Proliferation in a Mouse Model of Arteriovenous Stenosis: Opportunities for Intervention
por: Chan, Jenq-Shyong, et al.
Publicado: (2021)

Simulator-based hemodialysis cannulation skills training: a new horizon?
por: Singapogu, Ravikiran, et al.
Publicado: (2020)

Endpoint surrogacy in oncology Phase 3 randomised controlled trials
por: Zhang, Jianrong, et al.
Publicado: (2020)

Special issue on electrophysiology and arrhythmia management around the globe: Challenges and opportunities explored
por: Srivatsa, Uma N.
Publicado: (2022)

Patient-Reported Outcomes as Endpoints in Clinical Trials of Kidney Transplantation Interventions
por: Tong, Allison, et al.
Publicado: (2022)

Imaging endpoints for clinical trials in Alzheimer’s disease
por: Cash, David M, et al.
Publicado: (2014)

Examining the endpoint impacts, challenges, and opportunities of fly ash utilization for sustainable concrete construction
por: Orozco, Christian, et al.
Publicado: (2023)

Personalized Medicine in Ophthalmic Diseases: Challenges and Opportunities
por: Jin, Kai, et al.
Publicado: (2023)

Challenges present opportunities
por: Crouch, Eddie
Publicado: (2021)

2091: Evaluating the validity and utility of surrogate endpoints in clinical trials of chronic kidney disease (CKD)
por: Ying, Jian, et al.
Publicado: (2018)

The Fatigue Severity Scale in Interstitial Lung Disease: An Energizing Endpoint
por: Wong, Alyson W., et al.
Publicado: (2023)

Evolution of the Definition of Rejection in Kidney Transplantation and Its Use as an Endpoint in Clinical Trials
por: Becker, Jan Ulrich, et al.
Publicado: (2022)

Chronic Kidney Disease in Primary Care: An Opportunity for Generalists
por: Tuot, Delphine S., et al.
Publicado: (2011)

Decreasing Lean Body Mass with Age: Challenges and Opportunities for Novel Therapies
por: Boutari, Chrysoula, et al.
Publicado: (2017)

The Executive Order on Kidney Care: An Opportunity to Improve Outcomes for Individuals With Kidney Disease
por: Pearson, Jeffrey, et al.
Publicado: (2019)

Qualifying a Novel Clinical Trial Endpoint (iBOX) Predictive of Long-Term Kidney Transplant Outcomes
por: Klein, Amanda, et al.
Publicado: (2023)

Special Issue on “The Application of Metabolomics in Clinical Practice: Challenges and Opportunities”
por: Mussap, Michele
Publicado: (2022)

Exploring Signs and Symptoms Associated with Meibomian Gland Dysfunction for Use as Clinical Trial Endpoints
por: Ajouz, Layla, et al.
Publicado: (2023)

Podoconiosis today: challenges and opportunities
por: Deribe, Kebede
Publicado: (2018)

Pancreatic cancer: challenges and opportunities
por: Zhu, Huiyun, et al.
Publicado: (2018)

COVID-19: challenges and opportunities
por: Singer, Adam J, et al.
Publicado: (2020)

Opportunities and Challenges of Specialty Pharmaceuticals
por: Navarro, Robert P., et al.
Publicado: (2013)

IPF clinical trial design and endpoints
por: Nathan, Steven D., et al.
Publicado: (2014)

Ascertainment Bias in TB Treatment Trials: Can Systematic Assessment of Objective Endpoints Solve It?
por: Mitnick, Carole D., et al.
Publicado: (2023)

Single-cell transcriptome in the identification of disease biomarkers: opportunities and challenges
por: Zhu, Zhitu, et al.
Publicado: (2014)

Opportunities and challenges of clustering, crossing over, and using registry data in the PEPTIC trial
por: Young, Paul J., et al.
Publicado: (2023)

The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs
por: Phillips, Patrick PJ, et al.
Publicado: (2011)

Are component endpoints equal? A preference study into the practice of composite endpoints in clinical trials
por: Vaanholt, Melissa C.W., et al.
Publicado: (2018)

Surrogate endpoints… Uncommon for a common man!
por: Kumar, Ashish
Publicado: (2019)

Bridging the Gap: Exploring Opportunities, Challenges, and Problems in Integrating Assistive Technologies, Robotics, and Automated Machines into the Health Domain
por: Giansanti, Daniele
Publicado: (2023)

Exploring the intersections of structural inequities and health disparities: the challenge and opportunity of recognizing racism as a public health crisis
por: Lekas, Helen-Maria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0inperl8em7g2ev655imihvgjk